{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T13:58:03Z","timestamp":1774533483106,"version":"3.50.1"},"reference-count":56,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T00:00:00Z","timestamp":1729641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Lung enteric-type adenocarcinoma (ETAC) is a rare subtype of non-small cell lung cancer (NSCLC), comprising approximately 0.6% of all primary lung adenocarcinomas. It is characterized by a tendency for early metastasis and a prognosis comparable to that of common lung adenocarcinoma. This case report described a patient with lung-ETAC who developed gastric metastasis. The patient underwent treatment with chemotherapy and a PD-1 inhibitor, resulting in disease remission with a progression-free survival (PFS) of 8 months. The follow-up time was 13 months. This case report was aimed to enhance understanding of the biological behavior of this rare tumor and provide insights into potential future treatment strategies.<\/jats:p>","DOI":"10.3389\/fimmu.2024.1486214","type":"journal-article","created":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T04:50:50Z","timestamp":1729659050000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Lung enteric-type adenocarcinoma with gastric metastasis: a rare case report and literature review"],"prefix":"10.3389","volume":"15","author":[{"given":"Xiaoning","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kewei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaobo","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangye","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengge","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinghui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,10,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19911015)68:8<1754:aid-cncr2820680818>3.0.co;2-e","article-title":"Primary pulmonary adenocarcinoma with enteric differentiation","volume":"68","author":"Tsao","year":"1991","journal-title":"Cancer"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1097\/jto.0000000000000630","article-title":"The 2015 world health organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification","volume":"10","author":"Travis","year":"2015","journal-title":"J Thorac Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2021.11.003","article-title":"The 2021 WHO classification of lung tumors: impact of advances since 2015","volume":"17","author":"Nicholson","year":"2022","journal-title":"J Thorac Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-019-0207-y","article-title":"DNA methylation profiling reliably distinguishes pulmonary enteric adenocarcinoma from metastatic colorectal cancer","volume":"32","author":"Jurmeister","year":"2019","journal-title":"Mod Pathol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1097\/rlu.0000000000002171","article-title":"Diagnosis of multiple primary intestinal-type adenocarcinoma in the lung by 18F-FDG PET\/CT","volume":"43","author":"Hu","year":"2018","journal-title":"Clin Nucl Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1097\/rlu.0000000000004749","article-title":"Bilateral pulmonary enteric adenocarcinoma on FDG PET\/CT","volume":"48","author":"Su","year":"2023","journal-title":"Clin Nucl Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.21037\/jtd-19-4171","article-title":"Pulmonary enteric adenocarcinoma: a literature review","volume":"12","author":"Li","year":"2020","journal-title":"J Thorac Dis"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1177\/1724600819877190","article-title":"Cutaneous metastasis as a primary presentation of a pulmonary enteric adenocarcinoma","volume":"34","author":"Todisco","year":"2019","journal-title":"Int J Biol Markers"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2017.6060","article-title":"Pulmonary enteric adenocarcinoma with pancreatic metastasis: A case report","volume":"13","author":"Sun","year":"2017","journal-title":"Oncol Lett"},{"key":"B10","article-title":"A case of pulmonary enteric adenocarcinoma with soleus muscle metastasis","volume":"46","author":"Suzuki","year":"2019","journal-title":"Gan To Kagaku Ryoho"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.3390\/life13061291","article-title":"Deciphering lung adenocarcinoma heterogeneity: an overview of pathological and clinical features of rare subtypes","volume":"13","author":"Mogavero","year":"2023","journal-title":"Life (Basel)"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1159\/000325950","article-title":"Cytology of pulmonary adenocarcinomas showing enteric differentiation","volume":"50","author":"Satoh","year":"2006","journal-title":"Acta Cytol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s00428-023-03657-9","article-title":"Frequent nuclear \u03b2-catenin expression in pulmonary enteric-type adenocarcinoma according to the current World Health Organization criteria","volume":"483","author":"Kishikawa","year":"2023","journal-title":"Virchows Arch"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2017.04.006","article-title":"Clinicopathological, immunohistochemical, and mutational analyses of pulmonary enteric adenocarcinoma: usefulness of SATB2 and \u03b2-catenin immunostaining for differentiation from metastatic colorectal carcinoma","volume":"64","author":"Matsushima","year":"2017","journal-title":"Hum Pathol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2023.107176","article-title":"Clinical presentation and outcome of patients with enteric-type adenocarcinoma of the lung: A pooled analysis of published cases","volume":"179","author":"Fassi","year":"2023","journal-title":"Lung Cancer"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1097\/01.pas.0000160438.00652.8b","article-title":"Pulmonary adenocarcinomas with enteric differentiation: histologic and immunohistochemical characteristics compared with metastatic colorectal cancers and usual pulmonary adenocarcinomas","volume":"29","author":"Inamura","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2008.117","article-title":"Differential diagnostic and functional role of the multi-marker phenotype CDX2\/CK20\/CK7 in colorectal cancer stratified by mismatch repair status","volume":"21","author":"Lugli","year":"2008","journal-title":"Mod Pathol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-009-9072-4","article-title":"Small cell lung cancer: significance of RB alterations and TTF-1 expression in its carcinogenesis, phenotype, and biology","volume":"20","author":"Kitamura","year":"2009","journal-title":"Endocr Pathol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2021.101123","article-title":"Pulmonary enteric adenocarcinoma","volume":"14","author":"Gong","year":"2021","journal-title":"Transl Oncol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12967-018-1449-z","article-title":"Distinctive features of immunostaining and mutational load in primary pulmonary enteric adenocarcinoma: implications for differential diagnosis and immunotherapy","volume":"16","author":"Chen","year":"2018","journal-title":"J Transl Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104165","article-title":"Genomic and epigenomic profiles distinguish pulmonary enteric adenocarcinoma from lung metastatic colorectal cancer","volume":"82","author":"Zuo","year":"2022","journal-title":"EBioMedicine"},{"key":"B22","doi-asserted-by":"publisher","first-page":"107169","DOI":"10.1016\/j.lungcan.2023.03.005","article-title":"Genomic and transcriptomic insights into the precision treatment of pulmonary enteric adenocarcinoma","volume":"179","author":"Liu","year":"2023","journal-title":"Lung Cancer"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201606711","article-title":"Gene signature driving invasive mucinous adenocarcinoma of the lung","volume":"9","author":"Guo","year":"2017","journal-title":"EMBO Mol Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-023-00733-6","article-title":"Rare molecular subtypes of lung cancer","volume":"20","author":"Harada","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-21-0180","article-title":"Clinical and functional characterization of atypical KRAS\/NRAS mutations in metastatic colorectal cancer","volume":"27","author":"Loree","year":"2021","journal-title":"Clin Cancer Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s13045-021-01127-w","article-title":"Emerging strategies to target RAS signaling in human cancer therapy","volume":"14","author":"Chen","year":"2021","journal-title":"J Hematol Oncol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201606978","article-title":"NRAS destines tumor cells to the lungs","volume":"9","author":"Giannou","year":"2017","journal-title":"EMBO Mol Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-023-05386-7","article-title":"The disappearance of gastric metastasis and liver metastasis in non-small cell lung adenocarcinoma is due to osimertinib","volume":"149","author":"Wang","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"key":"B29","article-title":"Metastatic lung carcinoma involving the gastrointestinal tract","volume":"74","author":"Burbige","year":"1980","journal-title":"Am J Gastroenterol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19820101)49:1<170::aid-cncr2820490134>3.0.co;2-a","article-title":"Gastrointestinal metastases from Malignant tumors of the lung","volume":"49","author":"Antler","year":"1982","journal-title":"Cancer"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.31.1325","article-title":"Small cell lung cancer with extensive cutaneous and gastric metastases","volume":"31","author":"Maeda","year":"1992","journal-title":"Intern Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-017-9726-5","article-title":"Mutations of key driver genes in colorectal cancer progression and metastasis","volume":"37","author":"Huang","year":"2018","journal-title":"Cancer Metastasis Rev"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1097\/cm9.0000000000000266","article-title":"Clinical analysis of 23 patients pathologically diagnosed with primary and secondary pulmonary enteric adenocarcinoma","volume":"132","author":"Gu","year":"2019","journal-title":"Chin Med J (Engl)"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1099117","article-title":"Clinical features and prognosis of pulmonary enteric adenocarcinoma: A retrospective study in China and the SEER database","volume":"13","author":"Wang","year":"2023","journal-title":"Front Oncol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.cllc.2021.06.013","article-title":"Immune-checkpoint inhibitors in advanced non-small cell lung cancer with uncommon histology","volume":"23","author":"Manglaviti","year":"2022","journal-title":"Clin Lung Cancer"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2012.02.013","article-title":"Napsin A is an independent prognostic factor in surgically resected adenocarcinoma of the lung","volume":"77","author":"Lee","year":"2012","journal-title":"Lung Cancer"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1097\/pai.0000000000000632","article-title":"Clinicopathologic significance of intestinal-type molecules' Expression and different EGFR gene status in pulmonary adenocarcinoma","volume":"27","author":"Feng","year":"2019","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.988625","article-title":"A pulmonary enteric adenocarcinoma patient harboring a rare EGFR exon 19 P753S mutation: Case report and review","volume":"12","author":"Xu","year":"2022","journal-title":"Front Oncol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"bcr2012007667","DOI":"10.1136\/bcr-2012-007667","article-title":"Enteric adenocarcinoma lung: a rare presentation in an Omani woman","volume":"2013","author":"Qureshi","year":"2013","journal-title":"BMJ Case Rep"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1309\/ajcpb04xwictferl","article-title":"Primary pulmonary adenocarcinoma with intestinal differentiation mimicking metastatic colorectal carcinoma: case report and review of literature","volume":"131","author":"Li","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.lungcan.2019.10.005","article-title":"Next generation sequencing of lung adenocarcinoma subtypes with intestinal differentiation reveals distinct molecular signatures associated with histomorphology and therapeutic options","volume":"138","author":"Jurmeister","year":"2019","journal-title":"Lung Cancer"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1186\/s13000-022-01206-7","article-title":"Genetic mutation profiles and immune microenvironment analysis of pulmonary enteric adenocarcinoma","volume":"17","author":"Xie","year":"2022","journal-title":"Diagn Pathol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-023-01401-3","article-title":"Gefitinib, an effective treatment option for patients with pulmonary enteric adenocarcinoma harboring compound EGFR L858R and A871G mutation","volume":"41","author":"Cui","year":"2023","journal-title":"Invest New Drugs"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1266304","article-title":"Case report: Target and immunotherapy of a lung adenocarcinoma with enteric differentiation, EGFR mutation, and high microsatellite instability","volume":"14","author":"Yang","year":"2023","journal-title":"Front Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-019-0126-x","article-title":"Immunotherapy in colorectal cancer: rationale, challenges and potential","volume":"16","author":"Ganesh","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2020.07.014","article-title":"Efficacy and Safety of Sintilimab Plus Pemetrexed and Platinum as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC: a Randomized, Double-Blind, Phase 3 Study (Oncology pRogram by InnovENT anti-PD-1-11)","volume":"15","author":"Yang","year":"2020","journal-title":"J Thorac Oncol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1200\/jco.21.01497","article-title":"First-line immunotherapy for non-small-cell lung cancer","volume":"40","author":"Reck","year":"2022","journal-title":"J Clin Oncol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3332\/ecancer.2015.559","article-title":"Enteric-type adenocarcinoma of the lung harbouring a novel KRAS Q22K mutation with concomitant KRAS polysomy: a case report","volume":"9","author":"Metro","year":"2015","journal-title":"Ecancermedicalscience"},{"key":"B49","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13148-015-0162-5","article-title":"MicroRNA profiling of primary pulmonary enteric adenocarcinoma in members from the same family reveals some similarities to pancreatic adenocarcinoma-a step towards personalized therapy","volume":"7","author":"Garajov\u00e1","year":"2015","journal-title":"Clin Epigenet"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2015.2864","article-title":"Clinicopathological observation of primary lung enteric adenocarcinoma and its response to chemotherapy: A case report and review of the literature","volume":"11","author":"Lin","year":"2016","journal-title":"Exp Ther Med"},{"key":"B51","article-title":"Genetic mutations in lung enteric adenocarcinoma identified using next-generation sequencing","volume":"10","author":"Lin","year":"2017","journal-title":"Int J Clin Exp Pathol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2017.04.005","article-title":"Pulmonary adenocarcinoma with enteric differentiation presenting with bronchorrhea","volume":"12","author":"Prakobkit","year":"2017","journal-title":"J Thorac Oncol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v9.i30.9236","article-title":"Diagnosis and treatment of primary pulmonary enteric adenocarcinoma: Report of Six cases","volume":"9","author":"Tu","year":"2021","journal-title":"World J Clin cases"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.21873\/cdp.10102","article-title":"Combination of pembrolizumab with platinum-containing chemotherapy for pulmonary enteric adenocarcinoma","volume":"2","author":"Teranishi","year":"2022","journal-title":"Cancer Diagn Progn"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.799549","article-title":"Hyperprogressive disease after immunotherapy: A case report of pulmonary enteric adenocarcinoma","volume":"12","author":"Hu","year":"2022","journal-title":"Front Oncol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1290757","article-title":"Case report: Pathological complete response of pregnancy associated pulmonary enteric adenocarcinoma to chemoradiotherapy","volume":"14","author":"Nemoto","year":"2024","journal-title":"Front Oncol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1486214\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T04:50:52Z","timestamp":1729659052000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1486214\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,23]]},"references-count":56,"alternative-id":["10.3389\/fimmu.2024.1486214"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1486214","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,23]]},"article-number":"1486214"}}